Form 4: Foghorn Therapeutics Director Ian F. Smith Acquires 16,000 Stock Options
SEC Form 4
Director Ian F. Smith of Foghorn Therapeutics Inc. reports the acquisition of 16,000 stock options on June 26, 2024.
Summary
- On June 28, 2024, a Form 4 filing revealed that Ian F. Smith, a director at Foghorn Therapeutics Inc. (FHTX), acquired 16,000 stock options.
- The transaction occurred on June 26, 2024, with an exercise price of $5.52 per option.
- These options become exercisable on June 26, 2025, and expire on June 25, 2034.
- Following this transaction, Smith directly owns 16,000 derivative securities (stock options).
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock option acquisition by a director. The acquisition itself can be seen as a slightly positive sign, but the document is primarily informational.
Positives
- The acquisition of stock options by a director could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
This is a standard SEC filing related to insider transactions. It is common for directors and officers of publicly traded companies to receive stock options as part of their compensation.
Stakeholder Impact
- The acquisition of stock options by a director may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/21/2024 | Date of the Limited Power of Attorney execution. |
| 06/26/2024 | Date of the stock options acquisition. |
| 06/26/2025 | Date the stock options become exercisable. |
| 06/25/2034 | Expiration date of the stock options. |
| 06/28/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.